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Abstract
Resistance of bacteria to antibiotics is an urgent problem of humanity, which leads to 
a lack of therapy for serious bacterial infections. Development of new antibiotics has 
almost ceased in the last decades—even when a new antibiotic is launched, very soon 
the resistance of bacteria appears. There is a long list of applications where  antimicrobial 
­protection­ is­ required­ to­ achieve­ effective­ treatment.­ However,­ if­ we­ use­ the­ same­
 antibiotics for all these applications, we will remain caught in the “vicious circle” 




for designing alternative antimicrobial strategies is to go back to the antimicrobials that 
were used before the discovery of antibiotics, i.e., inorganic antimicrobial agents includ‐






























Resistance of bacteria to antibiotics is becoming an increasingly urgent problem of the  humanity. 
The most serious threat comes from vancomycin‐resistant Enterococcus­(VRE,­mainly­E.  faecium),­
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methicilin‐resistant Staphylococcus aureus­(MRSA),­Klebsiella­(especially­K. pneumoniae),­Acinetobacter 
baumanii, Pseudomonas aeruginosa, Enterobacter and Escherichia coli­(the­so‐called­“ESKAPE”­patho‐
gens,),­Gram‐positive­Mycobacterium tuberculosis and some other Gram‐negative bacteria [1]. 
Soon­there­will­be­no­available­antibiotics­to­treat­infections­with­these­pathogens.­The­problem­
first­appeared­in­hospitals­and­grew­promptly­as­a­consequence­of­uncontrolled­application­
of antibiotics not only in the healthcare but also in  agriculture, stock breeding, poultry breed‐
ing,­etc.­However,­overuse­and­misuse­are­not­the­only­factors­that­speed­up­the­spread­of­
resistance.­Some­mechanisms­of­resistance­do­not­destroy­the­antibiotic­and­leave­it­active­in­
the environment. Thus, bacteria themselves help maintain the antibiotic environment; fur‐
thermore, the drug can be released into other environments and alter them. Many precau‐
tions against drug misuse and overuse led to the reduction of antibiotic application in the 
last decade. Consequently, the spreading of resistance slowed down, but it did not decrease. 
We could get rid of the resistant strains with new antibiotics. Unfortunately, development 
of new antibiotics has almost ceased in the last decades. Investments in research and devel‐
opment­of­new­kinds­of­antibiotics­were­minimized­due­to­their­unprofitability.­And­even­
when a new antibiotic is launched, very soon the resistance of bacteria to the new antibiotic 
appears.
What can we deduce from all these facts? Instead of focusing only on development of new 
antibiotics, which will sooner or later create resistance, we should focus on preventing 
the resistance itself. There is a long list of applications where antimicrobial protection is 
required­in­order­to­achieve­effective­treatment.­However,­if­we­use­the­same­antibiotics­for­
all these applications, we will remain caught in the “vicious circle” of constant discovery of 
new synthetic antibiotics and very fast development of their resistant species. Therefore, we 
need­to­find­alternative­strategies­that­will­be­routinely­used­for­some­specific­conditions­
(such­as­ insufficient­ and­ slow­wound­healing,­ rejection­of­medical­ implants­during­ their­
 incorporation into the body due to the presence of bacteria on the surface of the implant, 
unsuccessful use of autologous, allogeneic or xenografts in tissue engineering because of the 
development­of­infection,­etc.).­Thus,­we­will­keep­the­activity­of­the­antibiotics­and­save­
them­for­urgent,­acute­conditions­(like­pneumonia,­meningitis,­peritonitis,­etc.).­One­option­
for designing these alternative antimicrobial strategies is to go back to the  antimicrobials 
that were used before the discovery of antibiotics, i.e., inorganic antimicrobial agents. There 
are a lot of inorganic substances with the capacity to kill bacteria or to inhibit bacterial 



















This chapter provides detailed overview of various inorganic antimicrobial agents, their 








infections until the discovery of penicillin and sulpha drugs completely drove it out from 
the market [2].­ In­ 1965,­ the­ favourability­ of­AgNO
3




 solution was established [2, 3]. In spite of reduced mortality from severe burns and 
strong action against Staphylococcus aureus, haemolytic streptococci, Pseudomonas aeruginosa 
and Escherichia coli,­the­0.5%­AgNO
3




 was hypotonic, sensitive to light,  inactive against 





Ca2+, Mg2+ and Cl− depletion in serum [2–4].­Hence,­an­improvement­was­tried­by­ combining 
AgNO
3
­with­a­ sulpha­drug­ to­obtain­ silver­ sulphadiazine­ [2].­Many­other­ ionic­Ag­drugs­
emerged,­but­Ag‐sulfadiazine­remained­the­most­widely­used,­although­it­delays­the­wound­
healing process [2, 5].­Further­development­went­to­systems­for­controlled­delivery­of­Ag+ 
ions,­Ag‐containing­wound­dressings,­catheters­and­antibacterial­coatings­[6, 7]­which­flooded­
the market recently [8].
The­antibacterial­action­of­Ag+ ions is currently explained by three mechanisms:
1. Ag+ ions react with thiol groups of the respiratory and transport proteins in the cell 
 membrane [6, 9] so that cellular respiration and electron transfer are blocked [6, 9], 
 membrane potential and permeability are disrupted, leading to cell death [10].
2. Ag+ ions enter the bacterial cells either through ion channels or due to the detachment of 
the cytoplasm membrane [9, 11].­Once­inside,­they­complex­with­nucleobases­of­DNA­and­
RNA­leading­to­DNA­condensation­and­loss­of­replication­ability­[6, 9, 12].
3. Increased­production­of­reactive­oxygen­species­(ROS).­Disruption­of­cellular­respiration­
and inactivation of intracellular thiol‐based antioxidants increases the oxidative stress 








for P. aeruginosa, E. coli, S. aureus­and­human­fibroblasts­are­very­similar­and­that­thiol‐containing­
molecules reduce their toxicity towards both prokaryotes and eukaryotes [14].
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2.2. Copper (I, II) (Cu+, Cu2+)
Cu+/2+­has­also­been­known­as­a­sterilizing,­antiseptic­and­antimicrobial­agent­[15] used to treat 
a­variety­of­skin­diseases,­syphilis,­tuberculosis­and­anaemia,­and­to­fight­mildew­[10, 16, 17]. 
In­modern­healthcare,­the­antimicrobial­effect­of­Cu­is­very­effectively­used­in­hospital­water­
distribution systems [16, 17]. Recent research has focused on “contact killing” mechanism [17]. 
In­2008,­the­US­Environmental­Protection­Agency­(EPA)­proclaimed­Cu‐surfaces­as­efficient­




and­50­μg­per­kg­body­weight­per­day­in­infants­are­recommended­by­the­WHO­[16, 20]. Cu 
ions are also toxic to prokaryotes and eukaryotes at higher cellular concentrations, and the 
involvement­of­Cu­(and­Zn)­in­phagosomal­killing­of­bacteria­engulfed­by­­macrophages­is­an­
important defence mechanism [10, 21].
The­antibacterial/toxicity­action­of­Cu(I,­II)­is­currently­explained­by­the­following­mechanisms:
1. Direct­ generation­ of­ ROS­ through­ Fenton‐type­ reactions­ [19, 22]. Radicals can cause 
 oxidative damage to proteins, nucleic acids and lipids, which lead to cell death [23].
2. Indirect generation of reactive oxygen species by inactivation of antioxidants and thiol 
depletion [19, 23].­Such­reactions­of­Cu­can­lead­to­the­inhibition­of­respiratory­enzyme­
function­and­disruption­of­respiration­leads­to­ROS­as­explained­for­Ag+ [6].
3. Competition with other metal ions for important binding sites on proteins [6, 17, 19]. 
­Site‐specific­inactivation­by­Cu­ions­can­also­occur­in­Fe‐S­dehydratases,­the­cytoplasmic­
enzymes­needed­to­make­branched‐chain­amino­acids­[17, 23].





 was  required 
for­the­DNA­breakage,­which­questions­the­relevance­of­this­mechanism­[16].
Bacteria­have­evolved­a­range­of­mechanisms­to­protect­themselves­from­the­toxic­effects­of­
excess Cu ions: exclusion by a permeability barrier; intra‐ and extracellular  sequestration 
of Cu ions by cell envelopes and metallothionein‐like Cu‐scavenging proteins in the 
­cytoplasm­ and­ periplasm;­ active­ transport­ membrane­ efflux­ pumps;­ reduction­ in­ the­
 sensitivity of  cellular targets to Cu ions; extracellular chelation or precipitation by secreted 
metabolites including Cu; and adaptation and tolerance via up‐regulation of necessary 
genes in the  presence of Cu [16, 19, 25].­Active­extrusion­of­Cu­from­the­cell­appears­to­be­
the chief mechanism of Cu tolerance in bacteria and has been extensively studied in  Gram‐
positive­ and­Gram‐negative­ bacteria.­However,­ due­ to­ the­multiple­ targets­ and­mostly­
non‐specific­mechanisms­ of­ damage­ exerted­ by­Cu,­ this­ bacterial­ tolerance­ is­ relatively­
low,­ as­ compared­ to­ the­ resistance­ to­ antibiotics­ (i.e.,­ 10‐fold­ lower­ sensitivity­ to­Cu­as­




Zn2+­ is­ also­ an­ essential­ micronutrient­ for­ the­ development,­ growth­ and­ ­differentiation­
of all  living systems, including bacteria, and exhibits antibacterial action only at higher 
 concentrations when its homeostasis is overcome. The adult human body contains approxi‐
mately 1.5–2.5 g of Zn2+ [22, 26–28] with essential role in cell membrane integrity,  development 
and maintenance of the body's immune system, managing insulin action and blood glucose 
­concentration,­bone­and­teeth­mineralization,­normal­taste­and­wound­healing­[22]. Zn is a 
constituent­of­more­than­300­enzymes­that­have­a­central­role­in­reconstruction­of­the­wound­
matrix [26, 29].­Zn­in­castor­oil­has­a­special­place­in­the­treatment­of­nappy­(diaper)­rash­
[26].­A­vast­ range­of­ zincated­bandages,­ dressings,­ emollients,­ shampoos­ and­ creams­ are­
available commercially. In normal wound healing, body creates a higher amount of Zn2+ in 
the wound margin at a certain stage—during the formation of granulation tissue, scar tissue 
and­re‐epithelialization.­It­is­believed­that­the­addition­of­Zn­at­this­stage­might­accelerate­
wound­healing.­Experimental­studies­have­shown­that­topical­ZnO­reduced­the­initial­haem‐
orrhagic phase and promoted the regrowth of damaged skin and hair [26]. The antibacterial 
properties of Zn2+ ions are exploited especially in oral healthcare for prevention of caries, 
gingivitis­and­periodontitis.­Zn−­salts­are­used­in­mouthwashes­and­toothpastes­ [30]. The 




1. Inhibition­of­enzymes­that­contain­sulfhydryl­groups­and­require­Mg2+ ions; competitive 
inhibition­and­reaction­of­Zn(II)­with­sulfhydryl­groups­[30–32].
2. Zn2+­ions­inhibit­the­utilization­of­the­bacterial­carbon­source.­They­can­disrupt­the­metabo‐
lism of sugars as well as the amino acid metabolism.
3. Zn2+ reduces the acid tolerance of S. mutans by inhibiting the transmembrane proton‐ 
translocating­F‐ATPase,­which­is­the­main­engine­for­acid­tolerance­[30].
4. Zn(II)­ binds­ to­ the­membranes­ and­ slows­ down­ the­ growth­ of­ organisms­ [6], inhibits 
 protease‐induced adhesion [34] and reduces the net negative charge on the cell surface 
and, hence, increases co‐aggregation [34].
Resistance of bacteria to toxic levels of Zn2+ can be due to extracellular accumulation, sequestration 
by­metallothioneins,­intracellular­physical­sequestration,­and/or­can­be­efflux­based­[35].­A­
recent­ study­ compared­ the­ Cu­ and­ Zn­ resistance­ of­MRSA­ and­ ­methicillin‐­susceptible­ S. 
aureus in a global collection of species [36].­While­there­was­no­difference­in­their­Cu−­suscep‐
tibility,­there­were­significantly­more­Zn‐resistant­MRSA­strains,­which­also­had­an­encoded­
Zn resistance [36].­Similarly­to­Ag,­recent­progress­of­­Zn−­­antimicrobials­has­gone­in­the­direc‐
tion­of­ZnO­nanoparticles­ and­ incorporation­of­ ionic­Zn­ into­ zeolites,­polymers,­ bioactive­
ceramics­and­glasses­to­achieve­better­efficiency­and­local­action­[6].




Antibacterial­ properties­ of­Ga3+­were­ first­mentioned­ in­ 1931­ [37]. Initially, it was mainly 
 investigated for cancer diagnosis and treatment [38, 39].­ Intensive­ research­ of­ Ga(III)­ as­
an­ ­antibacterial­ agent­ in­ the­ 2000s­ revealed­ great­ efficacy­ against­M. tuberculosis [40] and 




 at safe therapeutic dosage 
(10­mg/kg)­protects­mice­from­M. tuberculosis infection [43].­A­Phase‐1­clinical­study­is­being­
conducted­since­2010,­which­tests­Ganite­in­human­patients­suffering­from­cystic­fibrosis,­and­
chronically infected by P. aeruginosa [37, 38, 44]. Current results show that intravenous Ganite 
infusion for 5 days decreases the amount of P. aeruginosa in the lung without any serious 
adverse­effect­ [38, 44].­Subcutaneous­application­of­Ga‐maltolate­was­effective­ in­reducing­
S. aureus, A. baumannii and P. aeruginosa­colonization­in­burn­wounds­of­thermally­injured­
mouse model [42]. These data support a potential use of Ga‐maltolate in vivo,  especially 






[45], citrate [46], desferriox‐amine B and other complexes [46–48].
The following is currently known about the mechanism of antibacterial action of Ga3+ ions:
1. Ga3+ follows uptake and transport pathways for Fe3+;­unlike­Fe(III),­it­cannot­be­­reduced­
to­ the­ oxidation­ state­ (+2);­ small­ amounts­ of­ non‐bound­ Ga­ can­ exist­ in­ solution­ at­
­physiological­ conditions,­ versus­ insignificant­ amounts­ of­ non‐bound­ Fe3+,­ permitting­
 biological interactions for Ga3+ that would not be possible for Fe3+ [49, 50].
2. Most bacteria require Fe for growth [37]. If bacteria use Ga instead of Fe, it will prevent 
their­multiplication,­which­is­crucial­for­harming­the­organism­(as­observed­in­bacterial­
ferric‐binding protein and non‐ribosomal peptide microbial siderophores [49]).






 was noticed due to Ga3+ antibacterial action [51].­However,­
Ga3+ quenches the superoxide ion signal [51],­and­it­is­not­yet­clear­whether­the­ROSs­are­
the main reason or only a consequence of the Ga3+ antibacterial action.
Considerable progress has been recently made in the development of Ga delivery systems 
using phosphate‐based glasses [52–54], cellulose [55],­scaffolds­[56], phosphosilicates [57, 58] 
and titanium implants [59].­Because­bacteria­cannot­discriminate­between­Fe(III)­and­Ga(III),­
they will not sense an increase of Ga3+ concentration and a decrease of Fe3+.­However,­since­
Ga(III)­enters­microbial­cells­by­exploiting­specific­Fe(III)‐uptake­mechanisms,­­mutations­in­
these pathways could block Ga from reaching its cellular targets, ultimately making bacte‐
ria less susceptible to Ga's inhibitory activity, as it has been observed in laboratory  studies 
of­ Ga(III)­ antibacterial­ mechanism,­ in­ which­ resistant­ strains­ were­ created­ by­ genetic­
­modification­of­P. aeruginosa [60, 61].­Nevertheless,­such­mutations­could­never­completely­





Ag­ nanoparticles­ show­ bactericidal­ action­ in­ both­ Gram‐positive­ and­ Gram‐negative­
­bacteria,­with­higher­efficiency­induced­by­smaller­particles­[12, 32, 62] and quite intriguing 
dependence­of­the­efficiency­on­the­shape,­falling­in­the­order:­triangular­nanoplates,­nano‐
spheres, nanowires [63].­In­Ag­nanoparticles,­there­are­three­sources­of­bactericidal­activity:­




S‐containing­molecules­ (soft­ bases)­ [63–65].­ Then,­Ag­ ions­ are­ released­ into­ the­ cell­ and­
inhibit­respiratory­enzymes,­which­facilitates­the­generation­of­ROS­and­consequently­dam‐
















exposed to air prior to the antibacterial test under anaerobic conditions, their antibacterial 
properties were enhanced and bacterial survivability depended on released ions.
However,­the­amount­of­released­ions­from­the­Ag­NPs­at­their­MIC­was­always­lower­than­




Importantly,­immobilized­Ag­NPs­were­more­efficient­than­Ag+ ion‐releasing substrates, even 
though­ they­ released­much­ lower­ amount­ of­ ions­ and­ the­ immobilized­Ag­NPs­were­not­
internalized­[72, 75].­Ag­NPs­can­change­the­lipid­composition­of­the­membrane,­anchor­and­
incorporate into the outer membrane, and it is currently believed that the outer membrane 
damage­ is­mainly­“nano‐specific”­ [72].­Ag­NPs­enhance­ the­ transport­of­Ag+ ions into the 








In­ Cu­ nanoparticles,­ there­ is­ a­ coincidence­ of­ antibacterial­ effect­ of­ ions­ and­ nano‐sized­
­particles.­The­efficiency­of­Cu­was­improved­by­decreasing­the­dimensions,­but­it­was­higher­
for Gram‐positive bacteria [32].­Cu­nanoparticles­have­great­affinity­for­amines­and­carboxyl­
groups, so they bind to the ones on the surface of bacteria and release the ions inside. These 
ions­can­then­interact­with­DNA­molecules­and­intercalate­with­nucleic­acid­strands­[77]. It 
is­believed­that­here,­the­role­of­ROS­is­much­larger­than­in­Ag­nanoparticles,­since­they­can­
be­generated­by­CuO­as­well­as­ the­released­Cu+/Cu2+ ions by their dissolution [78].­Some­






­NPs­[79]. In general, it 
has been shown that trends in bactericidal activity were similar to trends in cytotoxicity, i.e. 




can­become­strongly­bactericidal­ as­a­ consequence­of­photocatalysis.­ZnO­ is­ a­ semiconduc‐
tor­with­ a­direct­ 3.3‐eV­band­gap­ [82].­Absorption­of­ light­with­ energy­greater­ than­3.3­ eV­








amino acids and protein catalytic centres [83].­Negative­charge­of­OH•­and­O−•­prevents­these­





, which can pass into the cell and  create internal 
damage leading to cell death [82].­ZnO­nanoparticles­show­bactericidal­properties­as­well­as­
ROS­generation­also­in­complete­absence­of­light.­This­effect­has­been­tried­to­be­explained­by­
surface defects and the oxidative role of oxygen or halogens adsorbed on their surfaces [31, 82]. 
Such­a­mechanism­would­be­enhanced­in­an­aerobic­environment­and­it­was­observed­that­oxy‐
gen annealing and formation of nanoholes on the surface, which both stimulated a high amount 
of­adsorbed­oxygen­atoms­on­the­ZnO­surface,­increased­the­ROS­production­and­enhanced­the­










to weak interaction with bacterial surface because of negative charge. In contrast, recent stud‐
ies­have­shown­that­TiO
2







, it did not show up‐regulation 
of­ROS‐related­proteins­but­rather­caused­membrane­damage­via­direct­transfer­of­ROS­mol‐




visible‐light‐induced photocatalytic activity [85, 86].
3.5. Functionalized Au nanoparticles






nent is added to them [77, 85, 89]. Interestingly, some studies have also shown antibacterial 
activity­of­Au­nanoparticles­with­non‐antibacterial­components­added­to­them,­like­C/Au­core­
shell [94]­or­functionalized­Au­nanoparticles­[95–97].­Au­nanoparticles­as­carriers­enable­entry­
of­ the­added­molecules­ into­bacterial­ cells,­where­ they­ can­directly­ affect­ some­ important­
molecules, otherwise protected by the cell wall and membrane. Concentration of otherwise 
inactive­molecules­on­the­surface­of­Au­nanoparticle­enables­(or­increases)­some­interactions­
that lead to bacterial death [95]. In this way, 4,6‐diamino‐2‐pyrimidinethiol was able to chelate 
Mg2+­ions­when­attached­to­the­Au­nanoparticle­[95] and induced damage of the outer mem‐
brane,­leading­to­increased­permeability­of­the­cellular­membrane.­Nanoparticles­entered­the­
cell, where chelation of Mg2+­and­interaction­of­the­particles­with­DNA­resulted­in­inhibition­
of protein synthesis. Cell death followed as a consequence of leakage of intracellular contents 




microbial peptides was created and enabled strong electrostatic interactions between cationic 
functionalization­at­Au­NPs­and­bacterial­membrane­resulting­in­damage­of­the­membrane­
compactness and structure which provided antibacterial action in E. coli and S. aureus [97].
3.6. Gallium‐containing nanoparticles






E. coli and S. aureus [99].­However,­concentrations­up­ to­25­mg/L­ (133­μM)­exhibited­only­
very­weak­(towards­S. aureus)­or­no­inhibition­(towards­E. coli)­of­planktonic­growth.­Further­




­ nanorods­ (50×200­ nm)­ which­ created­
an­ inhibition­ zone­ in­ E. coli­ already­ at­ 25­ mg/L­ concentration,­ whereas­ at­ least­ 50­ mg/L­
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did­not­ create­ any­ inhibition­ zone.­ They­ also­presented­ good­photocatalytic­ properties­ of­
this­semiconductor­with­a­band­gap­of­4.9­eV,­but­photocatalysis­was­not­responsible­for­the­






nation [101].­Antibacterial­activity­was­shown­also­for­GaN­nanoparticles­(50­nm)­[102] and 











GaIn nanoparticles with release of Ga3+­ions­inside­HeLa­cells­[104]. The in vivo­injection­of­
these nanoparticles into mice caused no tissue damage, no allergic reaction, exhibited very low 
acute­toxicity­(maximum­tolerated­dose­of­700­mg/kg),­while­Ga­and­In­were­excreted­with­
both faeces and urine [104].­However,­the­antibacterial­properties­of­KGa[Fe(CN)6]/PVP­and­
eutectic­GaIn­alloy­nanoparticles­have­not­been­evaluated.­On­the­other­hand,­Narayanasamy­
et­al.­incorporated­Ga(III)‐tetraphenyl­porphyrin­into­polymer­nanoparticles­(average­size­of­
300­nm)­and­demonstrated­their­efficiency­against­Mycobacterium smegmatis as well as against 
HIV­ in­macrophages,­ and­did­not­ show­any­ sign­of­ cytotoxicity­ for­macrophages­ even­at­
2­mM­concentrations­despite­ internalization­of­ the­nanoparticles­ into­all­ compartments­of­
the cells [105].­Another­way­for­ the­ local­delivery­of­Ga(III)‐tetraphenyl­porphyrin­was­by­




on antibacterial performances of elemental Ga nanoparticles [107]­confirmed­activity­against­
P. aeruginosa­with­MIC­at­0.1­mg/ml,­low­toxicity­at­this­concentration­and­wide­therapeutic­
window, which gives a good promise to this material for further investigations and design 
for biomedical applications.
3.7. Nanostructured MgO
MgO­ exhibits­ a­ broad­ range­ of­ antimicrobial­ activities­ against­ both­ Gram‐positive­ and­





similar to antimicrobial peptides [112]. In both mechanisms’ descriptions, the surface defect 
Antibacterial Agents48
sites­were­ related­ to­ the­production­of­ROS.­ In­ the­ latter­ case,­ generation­of­ROS­ species­
was­attributed­to­defects­ in­general­ [111]. In the former case, oxygen could be reduced at 
the  surface oxygen vacancy [109].­ This­ is­ consistent­with­ the­mechanism­ of­ ROS­ species­
­generation­at­the­surface­of­MgO.­However,­for­this­to­happen,­energy­is­required­to­support­
electron transfer from vacancy towards the molecular oxygen [113].­Other­mechanism­of­ROS­
generation­was­completely­ ignored­in­explanation­of­MgO­antibacterial­activity­ [113]. Till 
date,­the­following­properties­of­MgO­are­known:­(i)­MgO­exhibits­contact‐based­antibacte‐
rial action [108];­(ii)­increasing­the­pH­in­bacterial­suspension­due­to­MgO­hydration­did­not­
contribute to its antibacterial  activity [108];­(iii)­dissolved­Mg2+ were not causing harm to bac‐
teria [108];­(iv)­AFM­and­SEM­morphology­studies­confirmed­deterioration­of­­bacterial­mem‐
brane, which  indicated  membrane leakage [111, 114];­(v)­TEM­study­showed­lack­of­MgO­
particle­internalization­in­bacteria,­which­indicated­that­MgO­particles­are­“doing­the­dam‐












defects­at­the­surface­of­nano‐textured­MgO­microrods­[118]. Magnesium is the second most 
abundant intracellular cation in the human body [119] essential in many physiological pro‐
cesses­like­enzyme­activity,­membrane­processes,­functioning­of­muscle­and­neural­tissue,­
and so on. [119].­The­clinical­study­showed­the­ability­of­MgO­to­reduce­hypertension­(1g­
for­21­days)­[120].­Although­in vitro­studies­pointed­out­toxic­effect­of­MgO­on­human­cells­
[121],­at­a­concentration­of­0.2­mg/ml­ in­suspension­MgO­particles­were­able­ to­eliminate­
bacteria while at the same time showed potential to exhibit bioactive properties on the cells. 
In­this­context,­there­is­a­possibility­to­exploit­multifunctional­properties­of­MgO­to­design­









 to mimic the myelo‐
peroxidase activity [122, 123].­The­activity­ is­a­characteristic­of­enzyme­in­human­neutro‐
phils, which eliminate bacteria via the catalysis of the hydrogen‐peroxide‐to‐hypochlorite 











generates­ROS­on­its­own­[125], which indicated the possibility to perform a unique mode 
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­ in­medicine­ is­ limited­by­ its­ relatively­high­ solubility­ in­aqueous­media­ (>1­g/L).­
So‐formed,­high­concentrations­of­vanadate­ions­are­toxic­to­human­cells­[126, 127]. In vitro 
studies also showed their bi‐phasic nature, as these ions stimulate proliferation of various 
types­of­ ­mammalian­cells­at­ low­concentrations­(up­to­10­μM)­[128, 129]. They exhibit an 
insulin‐mimicking action via the inhibition of  tyrosine phosphatase [130].­Orally­adminis‐
tered­vanadates­in­rat­models­­stimulated­the­orientation­of­the­fibroblasts­in­parallel­arrays­
early in the tissue‐repair process, i.e., vanadate ions can accelerate tissue repair [131–133]. 
Vanadates­improved­the­bone‐formation­rate,­mechanical­strength­and­mineralization­[134], 
while the pro‐oxidant potential of vanadates was not revealed in erythrocytes [135]. These 
studies­confirmed­the­bioactive­potential­of­vanadate­ions­when­they­are­properly­delivered,­
which­might­be­­effectively­applied­when­designing­the­antibacterial­drug‐delivery­system­to­
enable controlled delivery of vanadate ions.
4. Concluding remarks
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